2,145 results on '"Danchin, Nicolas"'
Search Results
102. Annual cost of stable coronary artery disease in France: A modeling study
103. European Resuscitation Council Guidelines for Resuscitation 2015 Section 8. Initial management of acute coronary syndromes
104. Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production
105. Effectiveness of Pretreatment With Dual Oral Antiplatelet Therapy
106. Primary care management of non-institutionalized elderly diabetic patients: The S.AGES cohort – Baseline data
107. Impact of prolonged dual antiplatelet therapy after acute myocardial infarction on 5-year mortality in the FAST-MI 2005 registry
108. Improved long-term survival after acute myocardial infarction: the success of comprehensive care from the acute stage to the long term
109. Ultrasensitive Troponin I and Incident Cardiovascular Disease
110. Care of patients with ST-elevation myocardial infarction:an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients
111. YI 2.4 Neural Baroreflex Sensitivity and Long-Term Effect of Antihypertensive Agents—A Pharmacological Substudy of the Paris Prospective Study III
112. Sleep disorders and oral health: a cross-sectional study
113. Effect of Coronary Thrombus Aspiration During Primary Percutaneous Coronary Intervention on One-Year Survival (from the FAST-MI 2010 Registry)
114. 1.6 Individual and Neighborhood Deprivation and Carotid Stiffness: The Paris Prospective III Study
115. Missed opportunities in secondary prevention with statins
116. Comparative non-persistence in the first year of treatment with oral anticoagulants in patients with atrial fibrillation: A French comprehensive nationwide study
117. Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study
118. Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial
119. Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: Insights from the French FAST-MI program over 15 years
120. Discharge Heart Rate and Mortality after Acute Myocardial Infarction
121. Weaknesses in Regional Primary Coronary Angioplasty Programs: Is There Still a Role for a Pharmaco-invasive Approach?
122. Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registry
123. Frequency of cardiovascular diseases and risk factors treated in France according to social deprivation and residence in an overseas territory
124. Two-year outcome of patients after a first hospitalization for heart failure: A national observational study
125. Comparison of Two Antiplatelet Therapy Strategies in Patients Undergoing Transcatheter Aortic Valve Implantation
126. Presentation and Revascularization Patterns of Patients Admitted for Acute Coronary Syndromes in France Between 2004 and 2008 (from the National Observational Study of Diagnostic and Interventional Cardiac Catheterization [ONACI])
127. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure
128. L’infarctus du myocarde en France métropolitaine de 1995 à 2010 : évolution de la typologie des patients, de la prise en charge et du pronostic à court terme
129. One-Year Survival After ST-Segment–Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy: The FAST-MI Program
130. Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes†
131. Databases, registries, and quality of care
132. A data-driven pipeline to extract potential adverse drug reactions through prescription, procedures and medical diagnoses analysis: application to a cohort study of 2,010 patients taking hydroxychloroquine with an 11-year follow-up
133. Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France
134. Coronary artery embolism and acute coronary syndrome: A critical appraisal of existing data
135. In-hospital cardiac arrests admitted alive in intensive care units: Insights from the CubRéa database
136. Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial
137. Secretory Phospholipase A2-IIA and Cardiovascular Disease: A Mendelian Randomization Study
138. Real-life effectiveness of statins in the prevention of first acute coronary syndrome in France: A prospective observational study
139. First hospitalization for heart failure in France in 2009: Patient characteristics and 30-day follow-up
140. Evaluation of the impact of the recent controversy over statins in France: The EVANS study
141. The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents
142. Study Design and Baseline Characteristics of the National Observational Study of Diagnostic and Interventional Cardiac Catheterization by the French Society of Cardiology
143. National Observatory on the Therapeutic Management in Ambulatory Care Patients Aged 65 and Over, with Type 2 Diabetes, Chronic Pain or Atrial Fibrillation
144. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010
145. Usefulness of Fetuin-A and C-Reactive Protein Concentrations for Prediction of Outcome in Acute Coronary Syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI])
146. Smoking in Patients With Chronic Cardiovascular Disease During COVID-19 Lockdown
147. Ultrasensitive Troponin I and Incident Cardiovascular Disease
148. Abstract 17811: Changes in Profile, Management and Early Mortality of STEMI Patients According to Gender. Data Over 20 Years From the FAST-MI Program 1995-2015
149. Abstract 17319: Changes in Profile and Early Outcomes of STEMI Patients According to Use of Reperfusion Therapy: Data Over 20 Years From the FAST-MI Program 1995-2015
150. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.